ICGI Articles

  • A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway

    Published: 24.09.2017

    Vistad I, Bjørge L, Solheim O, Fiane B, Sachse K, Tjugum J, Skrøppa S, Bentzen AG, Stokstad T, Iversen GA, Salvesen HB, Kristensen GB, Dørum A

    Acta Obstet Gynecol Scand, 96 (10), 1162-1169

    PubMed 28795770

    For more information, please contact: Gunnar B. Kristensen

  • Involvement of DPP9 in gene fusions in serous ovarian carcinoma

    Published: 11.09.2017

    Smebye ML, Agostini A, Johannessen B, Thorsen J, Davidson B, Tropé CG, Heim S, Skotheim RI, Micci F

    BMC Cancer, 17 (1), 642

    PubMed 28893231

    For more information, please contact: Francesca Micci

  • Genetic heterogeneity in leiomyomas of deep soft tissue

    Published: 28.07.2017

    Panagopoulos I, Gorunova L, Brunetti M, Agostini A, Andersen HK, Lobmaier I, Bjerkehagen B, Heim S

    Oncotarget. 2017 Jul 25;

    PubMed 28591699

    For more information, please contact: Ioannis Panagopoulos

  • Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer

    Published: 29.06.2017

    Proctor L, Pradhan M, Leung S, Cheng A, Lee CH, Soslow RA, Gilks CB, Talhouk A, McAlpine JM, Danielsen HE, Hoang LN (2017)

    Gynecol Oncol

    PubMed 28647100

    For more information, please contact: Manohar Pradhan

  • Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma

    Published: 21.06.2017

    Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)

    Virchows Arch

    PubMed 28643014

    For more information, please contact: Håvard E. Greger Danielsen

  • Molecular characteristics of uterine sarcomas

    Published: 16.05.2017

    For more information, please contact: Francesca Micci

  • Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression

    Published: 27.03.2017

    Agostini A, Brunetti M, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F

    Oncotarget, 8 (13), 21554-21560

    PubMed 28423547

    For more information, please contact: Antonio Agostini

  • Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer

    Published: 28.02.2017

    Lund KV, Simonsen TG, Kristensen GB, Rofstad EK

    Acta Oncol, 56 (5), 675-681

    PubMed 28447564

    For more information, please contact: Gunnar B. Kristensen

  • Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)

    Published: 14.02.2017

    Lindemann K, Gibbs E, Åvall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dørum A, Gebski V, Kristensen G

    Br J Cancer, 116 (4), 455-463

    PubMed 28118323

    For more information, please contact: Gunnar B. Kristensen

  • Recurrent fusion transcripts in squamous cell carcinomas of the vulva

    Published: 08.02.2017

    Brunetti M, Agostini A, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F

    Oncotarget

    PubMed 28186972

    For more information, please contact: Marta Brunetti

  • « 1 2 3 4 5  ... Previous Next » 

Chief Editor: Prof. Håvard E. Danielsen
Copyright Oslo University Hospital. Visiting address: The Norwegian Radium Hospital, Ullernchausséen 64, Oslo. Tel: 22 78 23 20